Wolff Wiese Magana’s SpringWorks Therapeutics SWTX Stock Holding History

Wolff Wiese Magana’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34	Closed	-$1.6K	–	1037
2025 Q2	$1.6K	Hold	34	–	–	﹤0.01%	760
2025 Q1	$1.5K	Sell	34 -134	-80%	-$6.17K	﹤0.01%	785
2024 Q4	$6.07K	Hold	168	–	–	﹤0.01%	512
2024 Q3	$5.38K	Buy	+168	New	+$6.28K	﹤0.01%	559

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolff Wiese Magana's SWTX Position: Q3 2025 in Review

Wolff Wiese Magana sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 34 shares — an estimated $1.6K sold.

Wolff Wiese Magana first reported a position in SWTX in Q3 2024 and held it in 4 quarters. The position peaked at $6.07K in Q4 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Wolff Wiese Magana reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Wolff Wiese Magana sold 34 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.6K.
Wolff Wiese Magana first reported a position in SpringWorks Therapeutics in Q3 2024 and held it in 4 quarters.
Wolff Wiese Magana's SpringWorks Therapeutics position peaked at $6.07K in Q4 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.